Merck Buys Millipore
Millipore Corporation (NYSE:MIL), a leading life science company, and Merck & Co. Inc. (NYSE:MRK), a global pharmaceutical and chemicals company, entered into a definitive agreement under which Merck will acquire all outstanding shares of common stock of Millipore for US$107 per share in cash, or a total transaction value, including net debt, of approximately €5.3 ...
Recent Posts:
- Exelon Beats, Raises Estimates
- Viacom Upgraded By Fitch
- Wells Fargo Beats Estimates
- HDFC Bank’s Profit Escalates
- ITW In-Line With Zacks Estimate
- MarkWest Upgraded To Outperform
- Bristol Myers Beats By A Penny
- How Chinese Tweets Can Pad Your Nest With Cash
- Median Home Price Reaches 20-Month High
- Analyst Interviews: Oil & Gas Industry Stock Review
- U.S. Bancorp: A Penny Ahead
- Stock Buy: Apple, Inc.
- Yahoo! Slides On Search Concerns
- Mutual Funds: Top 5 Precious Metals Funds
- Juniper Misses Zacks Numbers
- Eaton’s Earnings Climb
- NextEra Energy Sells Wind Power
- Earnings Preview: JAKKS
- Honda To Roll Out More Hybrids
- Aussie Awaits Stress Test, Inflation Data